Sensory ganglionopathy is characterized by sensory loss without weakness. A common pathophysiological mechanism is autoimmunity. This review focuses on acquired sensory ganglionopathies, most commonly seen in patients with an autoimmune disease or a paraneoplastic disorder.
No takes yet. Share an insight, caveat, or question.
Amato et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: